Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cannara Biotech (TSE:LOVE)
TSXV:LOVE
Holding TSE:LOVE?
Track your performance easily
LOVE Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.52 - C$1.04
Previous CloseC$0.7
Volume71.43K
Average Volume (3M)14.96K
Market Cap
C$60.31M
Enterprise ValueC$97.47M
Total Cash (Recent Filing)C$5.46M
Total Debt (Recent Filing)C$42.62M
Price to Earnings (P/E)11.9
Beta0.08
Next Earnings
Dec 05, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding90,018,952
10 Day Avg. Volume28,838
30 Day Avg. Volume14,963
Standard Deviation0.16
R-Squared0.10
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.77
Price to Sales (P/S)0.92
Price to Cash Flow (P/CF)3.50
P/FCF Ratio2.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cannara Biotech News
PremiumCompany Announcements
Cannara Biotech Hits Record Market Share in July
PremiumCompany Announcements
Cannara Biotech’s Revenue Soars in Q3 2024
PremiumCompany Announcements
Cannara Biotech Boasts Strong Q2 Growth
Options Prices
Currently, No data available
---
Ownership Overview
LOVE FAQ
What was Cannara Biotech’s price range in the past 12 months?
Cannara Biotech lowest stock price was C$0.52 and its highest was C$1.04 in the past 12 months.
What is Cannara Biotech’s market cap?
Currently, no data Available
When is Cannara Biotech’s upcoming earnings report date?
Cannara Biotech’s upcoming earnings report date is Dec 05, 2024 which is in 34 days.
How were Cannara Biotech’s earnings last quarter?
Cannara Biotech released its earnings results on Jul 23, 2024. The company reported C$0.022 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.022.
Is Cannara Biotech overvalued?
According to Wall Street analysts Cannara Biotech’s price is currently Overvalued.
Does Cannara Biotech pay dividends?
Cannara Biotech does not currently pay dividends.
What is Cannara Biotech’s EPS estimate?
Cannara Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannara Biotech have?
Cannara Biotech has 90,018,950 shares outstanding.
What happened to Cannara Biotech’s price movement after its last earnings report?
Cannara Biotech reported an EPS of C$0.022 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.448%.
Which hedge fund is a major shareholder of Cannara Biotech?
Currently, no hedge funds are holding shares in TSE:LOVE
---
Cannara Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
TSE:LOVE Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $196.8K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.94%
12-Months-Change
Fundamentals
Return on Equity
6.84%
Trailing 12-Months
Asset Growth
9.58%
Trailing 12-Months
Company Description
Cannara Biotech
Cannara Biotech Inc is engaged in production of indoor cannabis and derivative products for the Canadian and international markets. The company is building indoor cannabis cultivation facility in Quebec, Canada.
---
Technical Analysis
Cannara Biotech
―
Auxly Cannabis Group
―
Cresco Labs
―
Green Thumb Industries
―
Trulieve Cannabis
―
---